ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,085.68
-1.26%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.055
0.00%
Brent Oil
82.765
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Mirum Pharmaceuticals Inc (MIRM)

  7. Mirum Pharmaceuticals Inc (MIRM) ニュース

MIRM Mirum Pharmaceuticals Inc

25.84
0.24 (0.94%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Mirum Pharmaceuticals Inc MIRM NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.24 0.94% 25.84 09:00:00
始値 安値 高値 終値 前日終値
26.01 25.66 26.24 25.84 25.60
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0205:10BWMirum Pharmaceuticals to Announce First Quarter 2024..
2024/4/1110:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2024/4/0221:30BWMirum Pharmaceuticals’ LIVMARLI (maralixibat oral solution)..
2024/3/2520:00GLOBESagimet Biosciences Announces Appointment of Tim Walbert and..
2024/3/1407:00BWMirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for..
2024/3/0909:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2024/3/0522:00BWMirum Pharmaceuticals to Participate in Upcoming Investor..
2024/2/2922:30BWHepatology Publishes Six-Year Data Demonstrating Improved..
2024/2/2907:01EDGAR2Form NT 10-K - Notification of inability to timely file Form..
2024/2/2906:05EDGAR2Form 8-K - Current report
2024/2/2906:03BWMirum Pharmaceuticals Reports Fourth Quarter and Year-End..
2024/2/2206:05BWMirum Pharmaceuticals to Announce Fourth Quarter and..
2024/2/1011:15BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2024/2/0611:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0611:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0311:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2609:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2609:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2609:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2011:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2024/1/1706:15EDGAR2Form 8-K - Current report
2024/1/1622:30BWMirum Pharmaceuticals Appoints Joanne Quan, MD as Chief..
2024/1/1109:00BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2024/1/1010:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1010:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1010:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0822:30EDGAR2Form 8-K - Current report
2024/1/0822:30BWMirum Pharmaceuticals Announces Preliminary Unaudited 2023..
2024/1/0322:45BWMirum Pharmaceuticals to Present at the 42nd Annual J.P...
2023/12/1906:06EDGAR2Form 8-K - Current report
2023/12/1822:30BWMirum Pharmaceuticals Announces Data from EMBARK Phase 2b..
2023/12/0909:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2023/12/0707:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0514:00BWLIVMARLI (maralixibat) di Mirum Pharmaceutical è stato..
2023/11/2106:05BWMirum Pharmaceuticals to Present at the 2023 Evercore ISI..
2023/11/1610:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1610:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1404:00BWMirum Pharmaceuticals Presents New Data at The Liver..
2023/11/1107:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
2023/11/0321:30BWMirum Pharmaceuticals to Present at the 2023 UBS Biopharma..
2023/11/0306:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/11/0305:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/0305:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0305:06EDGAR2Form 8-K - Current report
2023/11/0305:05EDGAR2Form 8-K/A - Current report: [Amend]
2023/11/0305:05BWMirum Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/10/3021:30BWMirum Pharmaceuticals to Present New Data at The Liver..
2023/10/2721:45BWMirum Pharmaceuticals to Announce Third Quarter 2023..
2023/10/1805:39EDGAR2Form 8-K - Current report
2023/10/1805:30BWMirum Pharmaceuticals Announces New PDUFA Date for LIVMARLI..

最近閲覧した銘柄

NASDAQ
MIRM
Mirum Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有